BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2098751)

  • 1. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z; Szponar J; Matuszek B; Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1990; 42(5):417-24. PubMed ID: 2098751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of antineoplaston A5 on the central dopaminergic structures.
    Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
    Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary pharmacological evaluation of chelidonine in rodents.
    Jagiełło-Wójtowicz E; Jusiak L; Szponar J; Kleinrok Z
    Pol J Pharmacol Pharm; 1989; 41(2):125-31. PubMed ID: 2594578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
    Kleinrok Z; Jagiełło-Wójtowicz E; Matuszek B; Chodkowska A
    Pol J Pharmacol Pharm; 1992; 44(3):227-39. PubMed ID: 1470561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
    Wawrzyniuk I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz
    Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evaluation of CNS effects of 6-O-substituted chelidonine derivatives.
    Jagiełło-Wójtowicz E; Chodkowska A; Gadzikowska M; Chojecka-Koryn E; Grynkiewicz G
    Acta Pol Pharm; 2003; 60(2):133-8. PubMed ID: 13678323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of O-acyl and O-alkyl chelidonine derivatives.
    Grynkiewicz G; Chojecka-Koryn E; Gadzikowska M; Chodkowska A; Jagiełło-Wójtowicz E
    Eur J Med Chem; 2001; 36(11-12):951-60. PubMed ID: 11755237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of alpha-adrenolytics on central action of agonists and antagonists of dopaminergic system.
    Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1977; 29(4):393-404. PubMed ID: 20609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
    Urba-Holmgren R; Holmgren B; Anias J
    Acta Neurobiol Exp (Wars); 1982; 42(2):115-25. PubMed ID: 6891988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of the effect of ketamine on some dopaminergic behaviors in rats.
    Morato GS; Takahashi RN
    Braz J Med Biol Res; 1986; 19(3):403-9. PubMed ID: 3594006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participation of prostaglandins E2 and F2 alpha in the action of fibrinopeptides A and B on the central dopaminergic system.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):29-39. PubMed ID: 3463941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
    Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
    Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some behavioural effects of chloroquine in rats suggesting dopaminergic activation.
    Amabeoku GJ
    Indian J Med Res; 1994 Feb; 99():87-94. PubMed ID: 8005645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clavulanic acid induces penile erection and yawning in male rats: comparison with apomorphine.
    Sanna F; Melis MR; Angioni L; Argiolas A
    Pharmacol Biochem Behav; 2013 Feb; 103(4):750-5. PubMed ID: 23234836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoclopramide decreases apomorphine-induced yawning and penile erection.
    Heaton JP; Varrin SJ
    Pharmacol Biochem Behav; 1991 Apr; 38(4):917-20. PubMed ID: 1871205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.